CompletedNot Applicable

Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Muscle Invasive Bladder Cancer

Egypt60 participantsStarted 2024-08-01

Plain-language summary

This research aimed to determine how accurately multiparametric magnetic resonance imaging (MRI), when interpreted using the VI-RADS scoring system, can distinguish between invasive and non-invasive bladder cancer.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Both sexes. * Patients with bladder masses diagnosed through ultrasound, computed tomography, or magnetic resonance imaging (MRI), who were scheduled for cystoscopy. Exclusion Criteria: * Contraindications to MRI (such as metallic prostheses or pacemakers). * Contraindications to Transurethral Resection (like unfitness for anesthesia or urethral strictures). * Elevated serum creatinine levels (precluding IV contrast-enhanced imaging).

What they're measuring

Sensitivity of VI-RADS score for invasion through the bladder wall

Timeframe: 3 months after the procedure

Trial details

NCT IDNCT07578233

SponsorAin Shams University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-03-01

View on ClinicalTrials.gov More Multiparametric trials